The history of Sildenafil presents a complex case for investors in the medicinal sector. While initially a phenomenal success, generating huge profits, the patent lapse and the subsequent arrival of generic alternatives have considerably affected revenue. This poses questions about the future profitability of similar drug developments and sugges… Read More